The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Atypical Hemolytic Uremic Syndrome
Open accessAbstract
Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. The atypical form of HUS is a disease characterized by complement overactivation. Inherited defects in complement genes and acquired autoantibodies against complement regulatory proteins have been described. Incomplete penetrance of mutations in all predisposing genes is reported, suggesting that a precipitating event or trigger is required to unmask the complement regulatory deficiency. The underlying genetic defect predicts the prognosis both in native kidneys and after renal transplantation. The successful trials of the complement inhibitor eculizumab in the treatment of atypical HUS will revolutionize disease management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Self-citationAtypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
Self-citationRother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 1×
“Eculizumab, a recombinant humanized monoclonal antibody directed against C5, blocks the cleavage of C5 into its effector components C5a and C5b.(106) Since the initial use of this complement inhibitor in aHUS in 2009,(107) the effectiveness of eculizumab has been communicated in many case reports, meeting abstracts, a…”
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationFremeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaimé, F., Dragon-Durey, M.-A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04760512 · Cited by 714
Atypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Self-citationMutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
Self-citationPregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fakhouri, F., Roumenina, L., Provot, F., Sallée, M., Caillard, S., Couzi, L., Essig, M., Ribes, D., Dragon-Durey, M.-A., Bridoux, F., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070706 · Cited by 467
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Complement control protein factor H: The good, the bad, and the inadequate
Ferreira, V. P., Pangburn, M. K., & Cortés, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.007 · Cited by 420
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Self-citationMutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133702 · Cited by 372
Self-citationMoore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Self-citationDragon-Durey, M.-A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W., & Weiss, L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115702.28859.a7 · Cited by 355
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
The European Paediatric Study Group for HUS, Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, C., Pecoraro, C., Taylor, C. M., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0964-1 · Cited by 352
Bresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Fremeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H. J., Alberti, M., Ribes, D., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090884 · Cited by 352
Self-citationManuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Nürnberger, J., Philipp, T., Witzke, O., Saez, A. O., Vester, U., Baba, H. A., Kribben, A., Zimmerhackl, L. B., Janecke, A. R., Nagel, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808527 · Cited by 346
T-cell regulation: with complements from innate immunity
Kemper, C., & Atkinson, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri1994 · Cited by 340
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Zipfel, P. F., Edey, M., Heinen, S., Józsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A. E., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030041 · Cited by 325
Self-citationRichards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., & Goodship, T. H. J. (2001) · The American Journal of Human Genetics · doi:10.1086/318203 · Cited by 310
Self-citationMaga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L., & Smith, R. J. H. (2010) · Human Mutation · doi:10.1002/humu.21256 · Cited by 308
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
CAPRIOLI, J., BETTINAGLIO, P., ZIPFEL, P. F., AMADEI, B., DAINA, E., GAMBA, S., SKERKA, C., MARZILIANO, N., REMUZZI, G., & NORIS, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122297 · Cited by 286
Esparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi066 · Cited by 281
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Besbas, N., Karpman, D., Landau, D., Loirat, C., Proesmans, W., Remuzzi, G., Rizzoni, G., Taylor, C. M., Van de Kar, N., & Zimmerhackl, L. B. (2006) · Kidney International · doi:10.1038/sj.ki.5001581 · Cited by 277
Taylor, C. M., Machin, S., Wigmore, S. J., Goodship, T. H. J., & on behalf of a working party from the Renal Association, T. B. C. F. S. I. H. A. T. B. T. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07916.x · Cited by 277
Self-citationEculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
Gruppo, R. A., & Rother, R. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0809959 · Cited by 275
Le Quintrec, M., Zuber, J., Moulin, B., Kamar, N., Jablonski, M., Lionet, A., Chatelet, V., Mousson, C., Mourad, G., Bridoux, F., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12077 · Cited by 268
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein
Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3831 · Cited by 246
Weiler, H., & Isermann, B. H. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00306.x · Cited by 238
Structural basis for engagement by complement factor H of C3b on a self surface
Morgan, H. P., Schmidt, C. Q., Guariento, M., Blaum, B. S., Gillespie, D., Herbert, A. P., Kavanagh, D., Mertens, H. D. T., Svergun, D. I., Johansson, C. M., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2018 · Cited by 237
Self-citationLechner, K., & Obermeier, H. L. (2012) · Medicine · doi:10.1097/md.0b013e3182603598 · Cited by 235
Józsi, M., Strobel, S., Dahse, H.-M., Liu, W.-S., Hoyer, P. F., Oppermann, M., Skerka, C., & Zipfel, P. F. (2007) · Blood · doi:10.1182/blood-2007-02-071472 · Cited by 233
Verhoef, G., Johnsen, H. E., Rossi, F. G., Salar, A., Hamilton, L., Schoonen, W. M., Pujol, B., & Duhrsen, U. (2008) · Blood · doi:10.1182/blood.v112.11.4948.4948 · Cited by 233
Fremeaux-Bacchi, V. A. A., Moulton, E. A., Kavanagh, D., Dragon-Durey, M.-A. G. A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101051 · Cited by 229
Self-citationSánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H
Schmidt, C. Q., Herbert, A. P., Kavanagh, D., Gandy, C., Fenton, C. J., Blaum, B. S., Lyon, M., Uhrín, D., & Barlow, P. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2610 · Cited by 208
Self-citationAbarrategui-Garrido, C., Martínez-Barricarte, R., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2009) · Blood · doi:10.1182/blood-2009-05-223834 · Cited by 206
Neumann, H. P. H., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.676 · Cited by 206
Complement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
New insights into postrenal transplant hemolytic uremic syndrome
Zuber, J., Le Quintrec, M., Sberro-Soussan, R., Loirat, C., Frémeaux-Bacchi, V., & Legendre, C. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.155 · Cited by 196
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Self-citationBienaime, F., Dragon-Durey, M.-A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.-A., Loirat, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.472 · Cited by 192
BAID, S., PASCUAL, M., WILLIAMS, W. W., TOLKOFF-RUBIN, N., JOHNSON, S. M., COLLINS, B., CHUNG, R. T., DELMONICO, F. L., COSIMI, A. B., & COLVIN, R. B. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101146 · Cited by 183
SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.01.003 · Cited by 180
Ferreira, V. P., Herbert, A. P., Cortés, C., McKee, K. A., Blaum, B. S., Esswein, S. T., Uhrín, D., Barlow, P. N., Pangburn, M. K., & Kavanagh, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804031 · Cited by 173
Self-citationFremeaux-Bacchi, V, Kemp, E. J., Goodship, J. A., Dragon-Durey, M.-A., Strain, L., Loirat, C., Deng, H.-W., & Goodship, T. H. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030783 · Cited by 171
Self-citationClark, S. J., Ridge, L. A., Herbert, A. P., Hakobyan, S., Mulloy, B., Lennon, R., Würzner, R., Morgan, B. P., Uhrín, D., Bishop, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201751 · Cited by 168
Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome
Saland, J. M., Ruggenenti, P., & Remuzzi, G. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080906 · Cited by 165
The complotype: dictating risk for inflammation and infection
Harris, C. L., Heurich, M., Cordoba, S. R. D., & Morgan, B. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.001 · Cited by 163
Roumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Dragon‐Durey, M., Blanc, C., Marliot, F., Loirat, C., Blouin, J., Sautès‐Fridman, C., Fridman, W. H., & Frémeaux‐Bacchi, V. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064766 · Cited by 156
Complement Regulatory Genes and Hemolytic Uremic Syndromes
Kavanagh, D., Richards, A., & Atkinson, J. P. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.060106.185110 · Cited by 155
Self-citationGenetics and complement in atypical HUS
Kavanagh, D., & Goodship, T. H. J. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1555-5 · Cited by 153
Self-citationMutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome
Frémeaux‐Bacchi, V., Goodship, T. H. J., Régnier, C. H., Dragon‐Durey, M., Janssen, B. J. C., & Atkinson, J. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.038 · Cited by 153
Self-citationCharacterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome
Kavanagh, D., Richards, A., Noris, M., Hauhart, R. E., Liszewski, M. K., Karpman, D., Goodship, J. A., Frémeaux‐Bacchi, V., Remuzzi, G., Goodship, T. H. J., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.004 · Cited by 152
Self-citationCombined kidney and liver transplantation for familial haemolytic uraemic syndrome
Remuzzi, G., Ruggenenti, P., Codazzi, D., Noris, M., Caprioli, J., Locatelli, G., & Gridelli, B. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08560-4 · Cited by 148
Fang, C. J., Frémeaux‐Bacchi, V., Liszewski, M. K., Pianetti, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2007) · Blood · doi:10.1182/blood-2007-04-084533 · Cited by 148
Self-citationSjöberg, A. P., Trouw, L. A., Clark, S. J., Sjölander, J., Heinegård, D. K., Sim, R. B., Day, A. J., & Blom, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610256200 · Cited by 146
Heinen, S., Sánchez‐Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K. E. C., Wagner, É., et al. (2006) · Human Mutation · doi:10.1002/humu.9408 · Cited by 144
Self-citationA prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
Roumenina, L. T., Frimat, M., Miller, E. C., Provôt, F., Dragon‐Durey, M., Bordereau, P., Bigot, S., Hue, C., Satchell, S. C., Mathieson, P. W., et al. (2012) · Blood · doi:10.1182/blood-2011-10-383281 · Cited by 142
Structural basis for complement factor I control and its disease-associated sequence polymorphisms
Roversi, P., Johnson, S., Caesar, J. J. E., McLean, F., Leath, K. J., Tsiftsoglou, S. A., Morgan, B. P., Harris, C. L., Sim, R. B., & Lea, S. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102167108 · Cited by 141
Tortajada, A., Montes, T., Martínez‐Barricarte, R., Morgan, B. P., Harris, C. L., & de Córdoba, S. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp289 · Cited by 141
Ståhl, A.-L., Vaziri‐Sani, F., Heinen, S., Kristoffersson, A., GYDELL, K., Raafat, R. H., Gutiérrez, A., Beringer, O., Zipfel, P. F., & Karpman, D. (2008) · Blood · doi:10.1182/blood-2007-08-106153 · Cited by 139
Richards, A., Liszewski, M. K., Kavanagh, D., Fang, C. J., Moulton, E. A., Frémeaux‐Bacchi, V., Remuzzi, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.004 · Cited by 131
Self-citationEsparza-Gordillo, J., de Jorge, E. G., Abarrategui-Garrido, C., CARRERAS, L., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.008 · Cited by 131
Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus
Nesher, G., Hanna, V. E., Moore, T. L., Hersh, M., & Osborn, T. G. (1994) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(94)90072-8 · Cited by 130
Factor H and Atypical Hemolytic Uremic Syndrome
Józsi, M., Heinen, S., Hartmann, A., Ostrowicz, C. W., Hälbich, S., Richter, H., Kunert, A., Licht, C. P. B., Saunders, R. E., Perkins, S. J., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080868 · Cited by 124
Jokiranta, T. S., Cheng, Z. ‐., Seeberger, H., Józsi, M., Heinen, S., Noris, M., Remuzzi, G., Ormsby, R. J., Gordon, D., Meri, S., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61205-9 · Cited by 118
The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
de Jorge, E. G., Macor, P., Paixão-Cavalcante, D., Rose, K. L., Tedesco, F., Cook, H. T., Botto, M., & Pickering, M. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050451 · Cited by 112
Blanc, C., Roumenina, L. T., Ashraf, Y., Hyvärinen, S., Sethi, S. K., Ranchin, B., Niaudet, P., Loirat, C., Gulati, A., Bagga, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200679 · Cited by 102
Lehtinen, M. J., Rops, A. L. W. M. M., Isenman, D. E., van der Vlag, J., & Jokiranta, T. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900814200 · Cited by 94
Complement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome
Vaziri‐Sani, F., Holmberg, L., Sjöholm, A. G., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000155 · Cited by 88
Kwon, T., Dragon‐Durey, M., Macher, M., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn063 · Cited by 88
Francis, N., McNicholas, B., Awan, A., Waldron, M., Reddan, D. N., Sadlier, D. M., Kavanagh, D., Strain, L., Marchbank, K. J., Harris, C. L., et al. (2011) · Blood · doi:10.1182/blood-2011-03-339903 · Cited by 86
Self-citationComplement therapy in atypical haemolytic uraemic syndrome (aHUS)
Wong, E. K. S., Goodship, T. H. J., & Kavanagh, D. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.224 · Cited by 86
Self-citationNilsson, S. C., Karpman, D., Vaziri‐Sani, F., Kristoffersson, A., Salomon, R., Provôt, F., Frémeaux‐Bacchi, V., Trouw, L. A., & Blom, A. M. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.10.005 · Cited by 85
Zadura, A. F., Zipfel, P. F., Bokarewa, M. I., Sturfelt, G. K., Jönsen, A., Nilsson, S. C., Hillarp, A., Saxne, T., Trouw, L. A., & Blom, A. M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4016 · Cited by 81
Richards, A., Kavanagh, D., & Atkinson, J. P. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96004-6 · Cited by 79
Self-citationPechtl, I. C., Kavanagh, D., McIntosh, N., Harris, C. L., & Barlow, P. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211839 · Cited by 75
Self-citationMatsuda, Y., Hara, J., Miyoshi, H., Osugi, Y., Fujisaki, H., Takai, K., Ohta, H., Tanaka‐Taya, K., Yamanishi, K., & Okada, S. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702003 · Cited by 75
Fan, X., Yoshida, Y., Honda, S., Matsumoto, M., Sawada, Y., Hattori, M., Hisanaga, S., Hiwa, R., Nakamura, F., Tomomori, M., et al. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.006 · Cited by 72
Dengue Fever-Induced Hemolytic Uremic Syndrome
Wiersinga, W. J., Scheepstra, C. G., Kasanardjo, J. S., de Vries, P. J., Zaaijer, H. L., & Geerlings, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/507111 · Cited by 71
Strobel, S., Abarrategui-Garrido, C., Requejo, E. F., Seeberger, H., Sánchez‐Corral, P., & Józsi, M. (2011) · Kidney International · doi:10.1038/ki.2011.152 · Cited by 69
Nilsson, S. C., Kalchishkova, N., Trouw, L. A., Frémeaux‐Bacchi, V., Villoutreix, B. O., & Blom, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939280 · Cited by 68
Hocking, H. G., Herbert, A. P., Kavanagh, D., Soares, D. C., Ferreira, V. P., Pangburn, M. K., Uhrín, D., & Barlow, P. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709587200 · Cited by 66
Self-citationKopp, A., Strobel, S., Tortajada, A., de Córdoba, S. R., Sánchez‐Corral, P., Prohászka, Z., López‐Trascasa, M., & Józsi, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200357 · Cited by 63
Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Pappworth, I. Y., Anderson, H. E., Hayes, C. M., Moore, I., Hunze, E.-M., Bennaceur, K., Roversi, P., Lea, S. M., Strain, L., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05750611 · Cited by 61
Self-citationCisplatin-Associated hemolytic uremic syndrome
Canpolat, C., Pearson, P., & Jaffe, N. (1994) · Cancer · doi:10.1002/1097-0142(19941201)74:11<3059::aid-cncr2820741125>3.0.co;2-z · Cited by 60
Transplantation in Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Richards, A., Goodship, T. H. J., & Jalanko, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1262887 · Cited by 54
Self-citationSartz, L., Olin, A. I., Kristoffersson, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100319 · Cited by 52
Quintrec, M. L., Zuber, J., Noël, L., Thervet, É., Frémeaux‐Bacchi, V., Fridman, W. H., Legendre, C., & Dragon‐Durey, M. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02586.x · Cited by 51
Larakeb, A. S., Leroy, S., Frémeaux‐Bacchi, V., Montchilova, M., Pelosse, B., Dunand, O., Deschênes, G., BENSMAN, A., & Ulinski, T. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0540-0 · Cited by 45
Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome
Monteferrante, G., Brioschi, S., Caprioli, J., Pianetti, G., Bettinaglio, P., Bresin, E., Remuzzi, G., & Noris, M. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.08.004 · Cited by 45
A novel mutation in the Complement Factor B gene (CFB) and atypical hemolytic uremic syndrome
Tawadrous, H. K., Maga, T., Sharma, J., et al. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1415-3 · Cited by 44
A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome
Ståhl, A.-L., Kristoffersson, A., Olin, A. I., Olsson, M. L., Roodhooft, A.-M., Proesmans, W., & Karpman, D. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.012 · Cited by 43
Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene
Westra, D., Vernon, K. A., Volokhina, E. B., Pickering, M. C., van de Kar, N. C. A. J., & van den Heuvel, L. P. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.57 · Cited by 43
Tortajada, A., Pinto, S., Martínez-Ara, J., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2011) · Kidney International · doi:10.1038/ki.2011.291 · Cited by 42
Ermini, L., Goodship, T. H. J., Strain, L., Weale, M. E., Sacks, S. H., Cordell, H. J., Frémeaux‐Bacchi, V., & Sheerin, N. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.003 · Cited by 41
Self-citationNovel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding
Volokhina, E. B., Westra, D., Xue, X., Gros, P., van de Kar, N. C. A. J., & van den Heuvel, L. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2183-z · Cited by 40
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation
Çaycı, F. Ş., Çakar, N., Hançer, V. S., Uncu, N., Acar, B. Ç., & Gür, G. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2283-9 · Cited by 39
Special Feature: Hemolytic-Uremic Syndrome Following “Crack” Cocaine Inhalation
Tumlin, J. A., Sands, J. M., & SOMEREN, A. O. (1990) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199006000-00002 · Cited by 36
Ardiles, L. G., Olavarría, F., Elgueta, M. S., Moya, P., & Mezzano, S. A. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000044936 · Cited by 35
Herbert, A. P., Kavanagh, D., Johansson, C. M., Morgan, H. P., Blaum, B. S., Hannan, J. P., Barlow, P. N., & Uhrı́n, D. (2012) · Biochemistry · doi:10.1021/bi201689j · Cited by 28
Self-citationBrown, J. H., Tellez, J. O., Wilson, V. A., Mackie, I. J., Scully, M., Tredger, M. J., Moore, I., McDougall, N., Strain, L., Marchbank, K. J., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.03991.x · Cited by 22
Self-citationWilson, C. H., Torpey, N., Jaques, B. C., Strain, L., Talbot, D., Manas, D., & Goodship, T. H. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.04.008 · Cited by 22
Self-citationEarly treatment with eculizumab in atypical haemolytic uraemic syndrome
Garjau, M., Azancot, M. A., Ramos, R., Sánchez‐Corral, P., Montero, M. A., & Serón, D. (2012) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr157 · Cited by 21
Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome
Kavanagh, D., & Anderson, H. E. (2011) · Kidney International · doi:10.1038/ki.2011.330 · Cited by 20
Self-citationMartínez‐Barricarte, R., de Jorge, E. G., Montes, T., García‐Layana, A., & de Córdoba, S. R. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03798.x · Cited by 14
Beware renal adverse effects of anti-vascular endothelial growth factor treatment
Keir, L. S., Moorsel, F. V., Saleem, M. A., & Richards, A. (2012) · BMJ · doi:10.1136/bmj.e3838 · Cited by 8
Self-citationFrimat, M., Roumenina, L. T., Tabarin, F., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.168 · Cited by 4
Cited by
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
Self-citationAtypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
International, F. H., Loirat, C., Fakhouri, F., Ariceta, G., Besbas, N., Bitzan, M., Bjerre, A., Coppo, R., Emma, F., Johnson, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3076-8 · Cited by 596
Complement, a target for therapy in inflammatory and degenerative diseases
Morgan, B. P., & Harris, C. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4657 · Cited by 431
Thrombotic Microangiopathy and the Kidney
Brocklebank, V., Wood, K. M., & Kavanagh, D. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00620117 · Cited by 373
Self-citation
Metadata
- Authors
- Kavanagh, D., Goodship, T. H., & Richards, A.
- Venue
- Seminars in Nephrology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 33
- Issue
- 6
- Pages
- 508-530
- ISSN
- 0270-9295 (ISSN-L)
- OpenAlex
- W2149943632
- Cited by
- 348
- References
- 123
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.